Therefore, some VGF fragments were considered as biomarkers for neurological and psychiatric disorders, such as Alzheimer's disease, frontotemporal dementia and schizophrenia [31]. This evidence concerns the gene VGF and early-onset autosomal dominant Alzheimer disease.